Beta 2 Glycoprotein 1 (β2GP1) - IgA Antibody, Serum
Overview
The Beta 2 Glycoprotein 1 (β2GP1) IgA Antibody test measures IgA antibodies directed against beta-2 glycoprotein 1, a protein involved in blood clotting. It is primarily used as part of the evaluation for Antiphospholipid Syndrome (APS), particularly when IgG and IgM antibodies are negative but clinical suspicion remains high.
Enables timely diagnosis and appropriate clinical management
When is this test recommended?
Your doctor may recommend this test if you have:
Recurrent miscarriages
Deep vein thrombosis (DVT)
Stroke or unexplained arterial thrombosis at a young age
Autoimmune disorders
Persistent suspicion of APS despite negative routine antibody tests
Interpretation
Negative: IgA antibodies not detected.
Positive: May indicate the presence of antiphospholipid antibodies and should be interpreted along with clinical findings and other laboratory tests (IgG, IgM β2GP1 antibodies, anticardiolipin antibodies, and lupus anticoagulant).
Note: A positive result alone does not confirm Antiphospholipid Syndrome. Clinical correlation and repeat testing after at least 12 weeks may be recommended.
Book Your Test Today
Advanced BioCare Laboratories provides accurate autoimmune testing with reliable reporting to support early diagnosis and better patient care.